Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities

Published:2024-07-03 Issue:8 Volume:13 Page:1861-1876
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Rofail Diana,Hussein Mohamed,Naumann Ulrike,Podolanczuk Anna J.,Norton Thomas,Ali Shazia,Mastey Vera,Ivanescu Cristina,Hirshberg Boaz,Geba Gregory P.

Funder

Regeneron Pharmaceuticals

Administration for Strategic Preparedness and Response

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-024-01013-1.pdf

Reference43 articles.

1. World Health Organization. WHO coronavirus (COVID-19) dashboard. 2024. https://covid19.who.int/. Accessed 17 Jan 2024.

2. Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293–302.

3. Rofail D, McGale N, Podolanczuk AJ, et al. Patient experience of symptoms and impacts of COVID-19: a qualitative investigation with symptomatic outpatients. BMJ Open. 2022;12(5):e055989.

4. Duggal P, Penson T, Manley HN, et al. Post-sequelae symptoms and comorbidities after COVID-19. J Med Virol. 2022;94(5):2060–6.

5. Rodebaugh TL, Frumkin MR, Reiersen AM, et al. Acute symptoms of mild to moderate COVID-19 are highly heterogeneous across individuals and over time. Open Forum Infect Dis. 2021;8(3):ofab090.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP